Gastric Cancer, MetastaticPhase 1/2NCT07509008
TROP2 CAR/IL-15 TGFBR2 KO NK Cells
TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum
2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
What the film says
This trial is for adults with advanced esophageal, stomach, or gastroesophageal junction cancer who are already on first line treatment.
The idea: inject 2141-V11 directly into a tumor while patients continue standard immunotherapy, with or without 5-FU chemotherapy. 2141-V11 is an antibody that switches on CD40, a receptor that can help start an immune response.
The study looks first at safety.
This phase 1 and 2 study plans 30 patients. At Memorial Sloan Kettering Cancer Center in New York, Samuel Cytryn leads it.
Public record; not medical advice.
Sources behind this film
Adults; advanced esophageal/gastric/GEJ adenocarcinoma on first-line therapy; Injected into tumor; continue anti-PD-1 with or without 5-FU; Antibody that activates CD40; Safety first (+1 more lines)
The drug
2141-V11 is a recombinant fully humanized IgG1 monoclonal antibody directed against CD40, which activates the CD40 receptor.
5-FU will be administered as a continuous infusion over 48 hours
The study
The purpose of this study is to find out whether adding the drug 2141-V11 to standard treatment (anti-PD-1 immunotherapy with or without 5-FU) is a safe treatment approach for participants with advanced esophageal, gastric, or gastroesophageal junction adenocarcinoma
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.